SCHEMBL3696799

SCHEMBL3696799

CC(C)n1cnc2c(N(C)c3ccc(-c4ccccn4)cc3)nc(Cl)nc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 14/20 0.51
▸ CDK2 P24941 14/20 0.51
▸ CCNA1 P78396 13/20 0.51
▸ CDK5 Q00535 11/20 0.51
▸ CDK5R1 Q15078 11/20 0.51
▸ DYRK1A Q13627 11/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ MDM2 Q00987 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ HTT P42858 1/20 0.45
▸ CDK9 P50750 7/20 0.44
▸ CCNT1 O60563 6/20 0.44
▸ CDK1 P06493 2/20 0.43
▸ CSNK1A1 P48729 4/20 0.43
▸ GSK3A P49840 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ CCNK O75909 2/20 0.43
▸ CDK12 Q9NYV4 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22022251 0.79 CDK2 (0.72) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL27573678 0.78 CDK2 (0.58) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL3696802 0.76 CDK1 (0.75) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL3646114 0.74 MEN1 (0.42) CDK2CDK5MAPTCCNE1
SCHEMBL25299779 0.71 CDK1 (0.62) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL27560716 0.71 CDK1 (0.51) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL14964230 0.71 CDK2 (0.59) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL14964239 0.71 DYRK1A (0.54) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL21019389 0.69 KDM4E (0.50) MAPTMAPK1TDP1HTT
SCHEMBL29326802 0.69 CDK2 (0.56) CCNA2CDK2CCNA1CDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2187889-B1 USE OF PURINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT CENTRE NAT RECH SCIENT (FR) 2013-11-06 — — EP disclosed
EP-2187889-A2 USE OF PURINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT Centre National De La Recherche Scientifique (FR) 2010-05-26 — — EP disclosed
WO-2009068761-A2 USE OF PURINE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-06-04 — — WO disclosed
Send feedback